My NCBISign In
The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now?
Josef S Smolen, Daniel Aletaha, Johannes Grisar, Kurt Redlich, Günter Steiner, Oswald Wagner
Arthritis Res Ther. 2008; 10(3): 208. Published online 2008 May 29. doi: 10.1186/ar2418
PMCID:
PMC2483438
Abstract Full Text PDF–1.5M

Is Cited by the Following 7 Articles in this Archive:

Interleukin 15 Levels in Serum May Predict a Severe Disease Course in Patients with Early Arthritis
Isidoro González-Álvaro, Ana M. Ortiz, José María Alvaro-Gracia, Santos Castañeda, Belen Díaz-Sánchez, Inmaculada Carvajal, J. Alberto García-Vadillo, Alicia Humbría, J. Pedro López-Bote, Esther Patiño, Eva G. Tomero, Esther F. Vicente, Pedro Sabando, Rosario García-Vicuña
PLoS One. 2011; 6(12): e29492. Published online 2011 December 29. doi: 10.1371/journal.pone.0029492
PMCID:
PMC3248461
Abstract Full Text PDF–338K Supplementary Material
Tocilizumab inhibits progression of joint damage in rheumatoid arthritis irrespective of its anti-inflammatory effects: disassociation of the link between inflammation and destruction
Josef S Smolen, José C Martinez Avila, Daniel Aletaha
Ann Rheum Dis. 2012 May 1; 71(5): 687–693. Published online 2011 November 25. doi: 10.1136/annrheumdis-2011-200395
PMCID:
PMC3329225
Abstract Full Text PDF–196K
Decreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis
Lucie Andrés Cerezo, Heřman Mann, Ondřej Pecha, Lenka Pleštilová, Karel Pavelka, Jiří Vencovský, Ladislav Šenolt
Arthritis Res Ther. 2011; 13(4): R122. Published online 2011 July 26. doi: 10.1186/ar3426
PMCID:
PMC3239361
Abstract Full Text PDF–825K
Validity of clinical associations of biomarkers in translational research studies: the case of systemic autoimmune diseases
Maria G Tektonidou, Michael M Ward
Arthritis Res Ther. 2010; 12(5): R179. Published online 2010 September 27. doi: 10.1186/ar3143
PMCID:
PMC2991010
Abstract Full Text PDF–575K Supplementary Material
Analysis of complex biomarkers for human immune-mediated disorders based on cytokine responsiveness of peripheral blood cells
John M. Davis, III, Keith L. Knutson, Michael A. Strausbauch, Cynthia S. Crowson, Terry M. Therneau, Peter J. Wettstein, Eric L. Matteson, Sherine E. Gabriel
J Immunol. Author manuscript; available in PMC 2011 June 15.
Published in final edited form as: J Immunol. 2010 June 15; 184(12): 7297–7304. Published online 2010 May 21. doi: 10.4049/jimmunol.0904180
PMCID:
PMC2882518
Abstract Full Text PDF–1.1M
Blood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis
Wolfgang Hueber, Beren H Tomooka, Franak Batliwalla, Wentian Li, Paul A Monach, Robert J Tibshirani, Ronald F Van Vollenhoven, Jon Lampa, Kazuyoshi Saito, Yoshiya Tanaka, Mark C Genovese, Lars Klareskog, Peter K Gregersen, William H Robinson
Arthritis Res Ther. 2009; 11(3): R76. Published online 2009 May 21. doi: 10.1186/ar2706
PMCID:
PMC2714123
Abstract Full Text PDF–1.3M Supplementary Material
Developments in the clinical understanding of rheumatoid arthritis
Josef S Smolen, Daniel Aletaha
Arthritis Res Ther. 2009; 11(1): 204. Published online 2009 January 30. doi: 10.1186/ar2535
PMCID:
PMC2688215
Abstract Full Text PDF–421K
You are here: NCBI > Literature > PubMed Central (PMC)
Write to the Help Desk